University of Minnesota Doctors Featured in TIME’s Top 100 Health Influencers

University of Minnesota Doctors Featured in TIME’s Top 100 Health Influencers

Two distinguished faculty members from the University of Minnesota have made it to TIME’s prestigious list of the Top 100 Health Influencers in 2026. Dr. Michael Osterholm and Dr. Emil Lou have been recognized for their significant contributions to public health and medical advancements.

Dr. Michael Osterholm: A Leader in Public Health

Dr. Michael Osterholm serves as the director of the Center for Infectious Disease Research and Policy at the university. With over 50 years of experience in shaping public health policy, he has previously held the position of the state’s epidemiologist.

TIME’s recognition highlights Osterholm as an “outspoken critic” of the recent shifts in U.S. vaccination policies. In December, federal health officials voted to alter recommendations regarding childhood hepatitis B vaccines, a decision that sparked concern among many medical experts. Osterholm commented, “For the first time, we can no longer count on our federal agencies to provide us scientifically sound information,” reflecting his worries about the reliability of health guidelines.

In response to these challenges, Osterholm initiated the Vaccine Integrity Project at the University of Minnesota. This initiative aims to deliver trustworthy, science-based information to help individuals make informed vaccine choices.

Dr. Emil Lou: Innovating Cancer Treatment

Dr. Emil Lou is a tenured professor and board-certified gastrointestinal oncologist affiliated with the university’s medical school and the Masonic Cancer Center. His work has been pivotal in developing pioneering immunotherapy cancer treatments.

TIME also recognized Lou alongside Minnesota resident Emma Dimery for their groundbreaking collaboration. Diagnosed with late-stage colon cancer at the age of 23, Dimery participated in a clinical trial under Lou’s guidance. The trial involved extracting cells from her tumor and using gene editing to make them resistant to her cancer’s evasion tactics.

Remarkably, after the edited cells were reinjected into Dimery’s body, her cancer disappeared within months. This innovative approach exemplifies the potential of cutting-edge treatments in oncology and highlights Lou’s role in advancing cancer care.

University’s Commitment to Future Health Professionals

U of M President Rebecca Cunningham expressed pride in both Osterholm and Lou’s achievements, stating they have “championed groundbreaking work in public health and medicine.” Their commitment to education inspires the next generation of health professionals.

These recognitions reaffirm the University of Minnesota’s role as a leader in health research and education, showcasing the impactful work of its faculty members.

Next